Karthik Radhakrishnan's Net Worth

-$6.31 Thousand

Estimate Recalculated Jul 3, 2024 05:24PM EST

Who is Karthik Radhakrishnan?

Karthik Radhakrishnan does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Opexa Therapeutics, Inc..

SEC CIK

Karthik Radhakrishnan's CIK is 0001573327

Past Insider Trading and Trends

2013 was Karthik Radhakrishnan's most active year for acquiring shares with 3 total transactions. Karthik Radhakrishnan's most active month to acquire stocks was the month of January. 2015 was Karthik Radhakrishnan's most active year for disposing of shares, totalling 1 transactions. Karthik Radhakrishnan's most active month to dispose stocks was the month of March. 2013 saw Karthik Radhakrishnan paying a total of $88,600.00 for 183,000 shares, this is the most they've acquired in one year. In 2015 Karthik Radhakrishnan cashed out on 50,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Opexa Therapeutics, Inc. (ACER) Snapshot price: $0.6601

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+66.97%
50K
—
—
124.66K
Apr 8
Form 4
—
0
—
—
0
Mar 2
Form 4
+28.72%
16.66K
—
—
74.66K
Feb 28
Form 4
+16.00%
8K
$1.70
$13,600.00
58K
Dec 18
Form 4
∞
50K
$1.50
$75,000.00
50K
Aug 8
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

Monopar Therapeutics (MNPR) No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found